Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statin therapy for stroke prevention.

Abdullah Nassief1, James D Marsh

  • 1Washington University School of Medicine, Saint Louis, MO, USA.

Stroke
|February 9, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronotherapy for hypertension: improvement in patient outcomes with bedtime administration of antihypertensive drugs.

European heart journal·2019
Same author

Dodecafluoropentane Emulsion in Acute Ischemic Stroke: A Phase Ib/II Randomized and Controlled Dose-Escalation Trial.

Journal of vascular and interventional radiology : JVIR·2019
Same author

Best Practices for Physician-Scientist Training Programs: Recommendations from the Alliance for Academic Internal Medicine.

The American journal of medicine·2018
Same author

U.S. Physician-Scientist Workforce in the 21st Century: Recommendations to Attract and Sustain the Pipeline.

Academic medicine : journal of the Association of American Medical Colleges·2017
Same author

Cigarette Smoking-Associated Alterations in Serotonin/Adrenalin Signaling Pathways of Platelets.

Journal of the American Heart Association·2017
Same author

Recruiting Faculty Leaders at U.S. Medical Schools: A Process Without Improvement?

Academic medicine : journal of the Association of American Medical Colleges·2017
Same journal

Management of Patients at Risk of Ischemic Stroke With Left Ventricular Systolic Dysfunction in the Absence of Intracardiac Thrombus: A Scientific Statement From the American Heart Association.

Stroke·2026
Same journal

Update on Rehabilitation After Stroke: Global Changes and the Continued Importance of Therapy Intensity, Dose, and Timing.

Stroke·2026
Same journal

ENTF Neuromodulation Yields Reduced Disability After Stroke: An Individual Participant-Level Data Meta-Analysis.

Stroke·2026
Same journal

Menopause and Its Implications for Stroke in Women.

Stroke·2026
Same journal

Physician Approaches to Determining Goals of Stroke Care for Patients Living With Disability or Dementia: Results from the SEED Mixed-Methods Study.

Stroke·2026
Same journal

Aspirin for Stroke Primary Prevention: A Step Toward Genetic-Driven Personalized Medicine.

Stroke·2026
See all related articles

Statins effectively reduce stroke risk in patients with and without coronary artery disease (CAD). This review of recent trials confirms statins

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Statins are primarily prescribed for cardiovascular risk reduction in patients with coronary artery disease (CAD).
  • Evidence for statin use in stroke risk reduction, particularly in patients without CAD, requires updated review.

Purpose of the Study:

  • To review recent clinical trials for new evidence on statin therapy's efficacy in reducing stroke risk.
  • To evaluate statin benefits across diverse patient populations, including those with and without CAD.

Main Methods:

  • Systematic review of recent clinical trials investigating statin use and stroke risk.
  • Analysis of data from trials such as TNT and SPARCL.

Main Results:

Related Experiment Videos

  • Statin therapy significantly reduces stroke risk in patients with CAD, with no increased risk of hemorrhagic stroke.
  • Evidence supports statin use for stroke risk reduction in patients without CAD who have high cardiovascular risk or diabetes mellitus.
  • Intensive statin therapy post-cerebrovascular event (SPARCL trial) reduced stroke risk and severity.

    • Conclusions:

    • Statins offer significant stroke risk reduction benefits beyond their established cardiovascular advantages.
    • Physicians should consider statin therapy for all individuals identified as high risk for stroke.